JUN 30, 2018 10:24 AM PDT

CD4 T Cells Responsible for Inflammatory Bowel Disease

WRITTEN BY: Kara Marker

A specific subset of immune cells could be targeted to better treat inflammatory bowel disease (IBD). A new University of Alabama at Birmingham study points out a population of cells that initiates and maintains the autoimmune reaction responsible for this chronic disease.

Crohn's chronic colitis, biopsy specimen. Credit: CoRus13

The new finding offers the chance for developing new therapeutic targets to treat – potentially even cure – IBD and other autoimmune diseases, should they also be involved. “We think these cells could be in a number of auto-inflammatory diseases,” explained Laurie Harrington, PhD. “Our hope is, if we could treat these cells, it could be curative.”

IBD includes Crohn’s disease and ulcerative colitis, which are mostly differentiated by which part of the gastrointestinal (GI) tract is affected by inflammation. In Crohn’s disease, inflammation usually affects any part of the GI tract, most often the lower small intestine. People with ulcerative colitis have inflammation in the large intestine and rectum.

Patients with either type of IBD experience diarrhea, abdominal pain, rectal bleeding, weight loss, and fatigue due to prolonged inflammation and damage in the GI tract. As an autoimmune disease, IBD represents a mistake in the immune response. Activity in the immune system is safe and necessary in the context of a bacterial or viral infection, but when immune cells accidentally target the body’s own tissues (in the case of IBD, cells of the GI tract), autoimmune diseases develop. Researchers know that IBD is caused by errors in immune activity, but any specific details beyond that concept are not understood.

In the present study, researchers studied a specific chemical messenger, a cytokine called interferon-gamma. It’s produced excessively by CD4 T cells, indicating a potential role in IBD pathology. CD4 T cells eventually differentiate into T helper cells of the adaptive immune system. In the new study, they looked at CD4 T cells in a mouse model of ulcerative colitis.

They found that CD4 T cells, depending on how they differentiated, were either pathogenic or not. Those cells that produced interferon-gamma could not confer colitis when transferred to healthy mice, but the cells that did not produce interferon-gamma did cause disease.

The same cells showed a similar genetic profile to stem cells, sharing a similar transcriptional signature. This observation indicated that these cells could also self-renew and resist the process of programmed cell death, called apoptosis.

The present study was published in Journal of Experimental Medicine.

Sources: Centers for Disease Control and Prevention, University of Alabama at Birmingham

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 22, 2019
JUL 22, 2019
How to Kill Superbugs
AUG 01, 2019
AUG 01, 2019
How cancer tricks our immune systems
Research published yesterday in Nature details the finding of a new “Don’t eat me” signal that cancers use to hide from the body’s ...
OCT 19, 2019
OCT 19, 2019
Autism May be Linked to an Immune Disorder
Until now, diagnosis for autism spectrum disorder have relied on behavioral assessments looking for symptoms including poor social and communication skills...
OCT 29, 2019
OCT 29, 2019
Antibody Discovered That May be the Key to a Universal Flu Vaccine
Instead of designing a new flu vaccine every year, researchers have made a breakthrough that may lead to a single vaccine that protects against all strains....
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
Vaccine To Protect Against The Zika Virus
Scientists at The University of Texas Medical Branch at Galveston present for the first time how a single high dose vaccine can protect a pregnant mouse al...
JAN 14, 2020
Clinical & Molecular DX
JAN 14, 2020
Can I eat this donut? A quick test for celiac disease.
Genetic testing revealed that our ancestors have been eating wheat, rye, spelt and barley for over 8,000 years. Today, gluten, a protein found within these...
Loading Comments...